Lynn Maslen
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 3
- SARS-CoV-2 detection and testing 1
- Virology 2
- Poxvirus research and outbreaks 2
- Co-authors
- Rohini Sharma (3 shared papers)David James Pinato (1 shared paper)Mario Pirisi (1 shared paper)Ramya Ramaswami (2 shared papers)Eric Ofori Aboagye (1 shared paper)Mark W. Anderson (1 shared paper)Craig M. McDonald (1 shared paper)Christopher Liddle (1 shared paper)
- Journals
- Nature Communications (2 papers)Nature (2 papers)The Lancet (1 paper)Nature Immunology (1 paper)Liver Cancer (1 paper)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Lynn Maslen
25 papers receiving 2.0k citations
Lynn Maslen's Hit Papers
Peers
Comparison fields: 5 of 65
- Infectious Diseases 1.1k
- Neurology 121
- Genetics 208
- Virology 13
- Immunology 41
Countries citing papers authored by Lynn Maslen
This map shows the geographic impact of Lynn Maslen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Maslen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Maslen more than expected).
Fields of papers citing papers by Lynn Maslen
This network shows the impact of papers produced by Lynn Maslen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Maslen. The network helps show where Lynn Maslen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lynn Maslen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses Hit paper breakdown → | 2022 | 746 |
| 2 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 3 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 4 | 2021 | 121 | |
| 5 | 2022 | 87 | |
| 6 | 2021 | 68 | |
| 7 | Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease Hit paper breakdown → | 2024 | 65 |
| 8 | 2023 | 32 | |
| 9 | Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study | 2022 | 27 |
| 10 | 2022 | 26 | |
| 11 | 2023 | 24 | |
| 12 | 2023 | 24 | |
| 13 | 2019 | 20 | |
| 14 | 1999 | 15 | |
| 15 | 2014 | 14 | |
| 16 | 2022 | 14 | |
| 17 | 2023 | 7 | |
| 18 | 2025 | 7 | |
| 19 | 2023 | 6 | |
| 20 | 2023 | 4 |
About Lynn Maslen
Lynn Maslen is a scholar working on Infectious Diseases, Virology, Genetics, Neurology and Pharmacology, having authored 27 papers that have together received 2.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Genetic Associations and Epidemiology (3 papers), Long-Term Effects of COVID-19 (2 papers), Poxvirus research and outbreaks (2 papers), SARS-CoV-2 detection and testing (1 paper), Pharmacogenetics and Drug Metabolism (1 paper) and Spinal Dysraphism and Malformations (1 paper). The work is most often cited by research in Infectious Diseases (1.1k citations), Neurology (121 citations), Genetics (208 citations), Virology (13 citations) and Immunology (41 citations). Lynn Maslen has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Rohini Sharma, David James Pinato, Mario Pirisi, Ramya Ramaswami, Eric Ofori Aboagye, Mark W. Anderson, Craig M. McDonald, Christopher Liddle, Stephen John Clarke and James E. Boggan. Their work appears in journals such as Nature Communications, Nature, The Lancet, Nature Immunology and Liver Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.